SC Filed 2024-04-01 Event — SEC 0001193125-24-083707 →

DNTH

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 37/100 · Filer 90d Win Rate: 60% · Hist. 90d Edge: +13.7%

Filer track record (10 filings): 60% 90d win rate, +13.7% 90d edge
Elevated short days-to-cover (10.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

55 transactions

5 buys · 28 sales · 22 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

22 filings by this filer

21 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 10.17

8,986,958 shares short · -1.7% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-08	Soteropoulos Paula	director	Option exercise	599	$8.44	$5K
2026-05-08	Soteropoulos Paula	director	Sale	599	$85.47	$51K
2026-04-09	Savitz Ryan	officer	Option exercise	8,224	$17.88	$147K
2026-04-09	Savitz Ryan	officer	Sale	8,224	$89.84	$739K
2026-03-31	Savitz Ryan	officer	Option exercise	74,367	$8.44	$628K
2026-03-31	Soteropoulos Paula	director	Option exercise	599	$8.44	$5K
2026-03-31	Soteropoulos Paula	director	Sale	599	$80.11	$48K
2026-03-31	Savitz Ryan	officer	Option exercise	40,000	$17.88	$715K
2026-03-31	Savitz Ryan	officer	Sale	1,390	$78.33	$109K
2026-03-31	Savitz Ryan	officer	Sale	21,825	$78.86	$1.72M
2026-03-31	Savitz Ryan	officer	Sale	1,485	$80.25	$119K
2026-03-31	Savitz Ryan	officer	Sale	800	$81.36	$65K
2026-03-31	Savitz Ryan	officer	Sale	2,366	$82.84	$196K
2026-03-31	Savitz Ryan	officer	Sale	59,800	$83.90	$5.02M
2026-03-31	Savitz Ryan	officer	Sale	19,469	$84.57	$1.65M
2026-03-31	Savitz Ryan	officer	Sale	7,232	$85.54	$619K
2026-03-24	Soteropoulos Paula	director	Option exercise	27,594	$8.44	$233K
2026-03-24	Soteropoulos Paula	director	Sale	27,594	$78.05	$2.15M
2026-03-16	Garcia Marino	director, officer	Option exercise	59,700	$6.70	$400K
2026-03-16	Garcia Marino	director, officer	Option exercise	5,592	$17.88	$100K
2026-03-12	Garcia Marino	director, officer	Option exercise	122,918	$6.70	$824K
2026-03-12	CARR EDWARD	officer	Option exercise	16,182	$17.88	$289K
2026-03-12	Randhawa Simrat	officer	Option exercise	7,998	$8.44	$68K
2026-03-12	CARR EDWARD	officer	Option exercise	17,500	$22.07	$386K
2026-03-12	CARR EDWARD	officer	Option exercise	10,000	$21.77	$218K

Showing 25 of 55

Other 13D/G Filings on Dianthus Therapeutics, Inc. /DE/

Filed	Form	Filer	Stake	Shares
2025-09-15	SCHEDULE	Fairmount Funds Management LLC	9.90%	4,052,052	view →

Other Filings by Fairmount Funds Management LLC

Filed	Form	Issuer	Stake	Shares
2026-10-15	SCHEDULE 13D	Alaunos Therapeutics, Inc.	19.99%	858,789	view →
2026-10-09	SCHEDULE 13D/A	SPYRE THERAPEUTICS, INC.	9.99%	9,354,200	view →
2026-09-11	SCHEDULE 13D	Korsana Biosciences, Inc.	19.99%	9,103,729	view →
2026-09-03	SCHEDULE 13D/A	Apogee Therapeutics, Inc.	—	0	view →
2026-07-20	SCHEDULE 13D/A	Crescent Biopharma, Inc.	—	6,593,385	view →
2026-07-01	SCHEDULE 13D/A	ORUKA THERAPEUTICS, INC. ORKA	19.50%	14,553,895	view →
2026-06-23	SCHEDULE 13D/A	SPYRE THERAPEUTICS, INC. SYRE	—	8,835,440	view →
2026-06-23	SCHEDULE 13D/A	Apogee Therapeutics, Inc. APGE	9.99%	6,713,519	view →
2026-06-09	SCHEDULE 13D/A	Jade Biosciences, Inc. JBIO	19.99%	14,069,494	view →
2026-05-13	SCHEDULE 13D/A	Viridian Therapeutics, Inc.\DE VRDN	—	17,201,800	view →
2026-01-22	SCHEDULE	Cogent Biosciences, Inc. COGT	9.90%	16,261,918	view →
2026-01-22	SCHEDULE	Apogee Therapeutics, Inc. APGE	9.99%	6,047,027	view →
2025-10-14	SCHEDULE	Apogee Therapeutics, Inc. APGE	9.99%	5,776,881	view →
2025-09-15	SCHEDULE	Dianthus Therapeutics, Inc. /DE/ DNTH	9.90%	4,052,052	view →
2025-03-10	SCHEDULE	Oruka Therapeutics, Inc. ORKA	19.99%	8,511,824	view →
2024-04-01	SC	Cogent Biosciences, Inc. COGT	—	—	view →
2024-04-01	SC	Viridian Therapeutics, Inc.\DE VRDN	—	—	view →
2024-04-01	SC	Apogee Therapeutics, Inc. APGE	—	—	view →
2023-12-11	SC	Spyre Therapeutics, Inc. SYRE	—	—	view →
2023-06-13	SC	Cogent Biosciences, Inc. COGT	—	—	view →

Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →